SuperGen is now Astex Pharmaceuticals

SuperGen, Inc. (NASDAQ: SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, announced it anticipates that it will begin operating under the name Astex Pharmaceuticals, Inc. on September 12, 2011. The new name follows the previously announced closing of its acquisition of Astex Therapeutics Limited, a privately held, UK-based biotechnology company developing targeted therapies. Astex Pharmaceuticals, Inc. is expected to begin trading on NASDAQ under the symbol ASTX on September 12, 2011.

Astex Therapeutics Limited became a wholly owned subsidiary of SuperGen, Inc. on July 20, 2011.